Citation Impact
Citing Papers
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
2008 Standout
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
2009 StandoutScience
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression
2003
Phase I Dose-Escalation Study of the Pan-HER Inhibitor, PF299804, in Patients with Advanced Malignant Solid Tumors
2011
Auditory recovery cycle dysfunction in schizophrenia: A study using event-related potentials
2005
Cerebellar morphology as a predictor of symptom and psychosocial outcome in schizophrenia
1999
EGFR Antagonists in Cancer Treatment
2008 Standout
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
2007 Standout
Corpus callosum size in schizophrenia - a magnetic resonance imaging analysis
1999
Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD.
1997 Standout
A computerized magnetic resonance imaging study of corpus callosum morphology in schizophrenia
1993
Magnetic Resonance Imaging of the Brain in Schizophrenia
1990
MRI brain abnormalities in chronic schizophrenia: One process or more?
1996
Widespread Cerebral Gray Matter Volume Deficits in Schizophrenia
1992
Quantitative magnetic resonance imaging of the corpus callosum in childhood onset schizophrenia
1997
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
2013 StandoutNature
Epigenetics: A Landscape Takes Shape
2007 Standout
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
2009 StandoutNature
Mismatch negativity (MMN), the deviance-elicited auditory deflection, explained
2009 Standout
Schizophrenia
2009 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Abnormalities of the Left Temporal Lobe and Thought Disorder in Schizophrenia
1992 Standout
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Subcortical and temporal structures in affective disorder and schizophrenia: A magnetic resonance imaging study
1992
Epigenetic therapy of cancer: past, present and future
2006
Cancer drug resistance: an evolving paradigm
2013 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Neuroimaging studies of mood disorder effects on the brain
2003
Recent Advances in the Neuropathology of Schizophrenia
1993
Meta-analysis of brain and cranial size in schizophrenia
1996
Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The morphology of the corpus callosum in schizophreniaAn MRI study
1988
MRI anatomy of schizophrenia
1999
MRI Study of Cavum Septi Pellucidi in Schizophrenia, Affective Disorder, and Schizotypal Personality Disorder
1998
Cerebral Glucose Metabolism in Adults with Hyperactivity of Childhood Onset
1990
Structural and Functional Characteristics of the Corpus Callosum in Schizophrenics, Psychiatric Controls, and Normal Controls
1990
Quantitative Cerebral Anatomy in Depression
1993
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
1999 StandoutNobel
Leisure Activities and the Risk of Dementia in the Elderly
2003 Standout
The Epigenomics of Cancer
2007 Standout
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
1991 Standout
Hemispheric asymmetries and schizophrenia: A preliminary magnetic resonance imaging study
1989
Procedural learning of cognitive and motor skills in psychotic patients
1992
Altered Distribution of Nicotinamide-Adenine Dinucleotide Phosphate—Diaphorase Cells in Frontal Lobe of Schizophrenics Implies Disturbances of Cortical Development
1993
Reduction of cortical volume in schizophrenia on magnetic resonance imaging
1993
Stroop interference and facilitation in the cerebral hemispheres in schizophrenia
1996
Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients
2003
Age at onset and sex differences in corpus callosum area in schizophrenia
1999
Cerebellar vermal size in schizophrenia: A male effect
1993
Epigenetics in Cancer
2008 Standout
Cavum septi pellucidi in normals and patients with schizophrenia as detected by magnetic resonance imaging
1997
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Structural brain imaging in schizophrenia: a selective review
1999
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
After Reaching Retirement Age Physical Activity Sustains Cerebral Perfusion and Cognition
1990
Targeting cancer with small molecule kinase inhibitors
2008 Standout
Frequency and Severity of Enlarged Cavum Septi Pellucidi in Childhood-Onset Schizophrenia
1998
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Frontal and non-frontal lobe neuropsychological test performance and clinical symptomatology in schizophrenia
1992
Effectiveness of imazodan for treatment of chronic congestive heart failure
1991
Basal ganglia and cerebellar loops: motor and cognitive circuits
2000
Quantitative Neuroanatomy in Schizophrenia
1988
Stress and the brain: from adaptation to disease
2005 Standout
ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal.
2005
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient mice
2000 Standout
Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia
1990
Midsagittal cortical pathomorphology of schizophrenia: A magnetic resonance imaging study
1989
"Cognitive Dysmetria" as an Integrative Theory of Schizophrenia: A Dysfunction in Cortical-Subcortical-Cerebellar Circuitry?
1998 Standout
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Qualitative cerebral morphology in schizophrenia: a magnetic resonance imaging study and systematic literature review
1997
Qualitative MRI findings in patients with schizophrenia: a controlled study
2000
Neurobiology of Depression
2002 Standout
A review of MRI findings in schizophrenia
2001 Standout
Correlation of Negative Symptoms in Schizophrenia with Frontal Lobe Parameters on Magnetic Resonance Imaging
1991
Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations.
2009
Frontal and callosal neuropsychological performances in schizophrenia
1991
Neuroimaging studies of schizophrenia
1991
Corpus callosum dimensions measured by magnetic resonance imaging in bipolar affective disorder and schizophrenia
1989
Wisconsin Card Sorting Test: an indicator of vulnerability to schizophrenia?
1992
Third-ventricle enlargement and neuropsychological deficit in schizophrenia
1992
Major Depressive Disorder
2008 Standout
Corpus callosum shape and size in male patients with schizophrenia
1998
Clinical consequences of angiotensin-converting enzyme inhibitor withdrawl in chronic heart failure: A double-blind, placebo-controlled study of quinapril
1993
Brain dysfunction during motor activation and corpus callosum alterations in Schizophrenia measured by cerebral blood flow and magnetic resonance imaging
1991
Corpus callosum size and inter-hemispheric function in schizophrenia
1997
Cavum septum pellucidum in schizophrenia: A magnetic resonance imaging study
1996
Integration of EGFR inhibitors with radiochemotherapy
2006
Chemical regulation of epigenetic modifications: Opportunities for new cancer therapy
2008
Monitoring fibrillar collagen turnover in hypertensive heart disease
1997
Reduced temporal lobe areas in schizophrenia: Preliminary evidences from a controlled multiplanar magnetic resonance imaging study
1990
Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope
1988
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
The molecular neurobiology of depression
2008 StandoutNature
Neuropsychological Deficits in Schizophrenics
1994
Neuroscience, Molecular Biology, and the Childhood Roots of Health Disparities
2009 Standout
An MRI study of cerebellar vermis morphology in patients with schizophrenia: evidence in support of the cognitive dysmetria concept
1999
Prevalence of cavum septum pellucidum detected by MRI in patients with bipolar disorder, major depression and schizophrenia
1996
Mapping Morphology of the Corpus Callosum in Schizophrenia
2000
Gender differences in corpus callosum size in first-episode schizophrenics
1994
The anatomy of mood disorders—review of structural neuroimaging studies
1997
Gender Differences in Schizophrenia on MRI Brain Scans
1990
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
1998 Standout
Mechanisms for oncogenic activation of the epidermal growth factor receptor
2007
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
2015 Standout
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
A magnetic resonance imaging study in first‐episode disorganized‐type patients with schizophrenia
1997
Spatial relationships of neuroanatomic landmarks in schizophrenia
1996
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Regional Brain Abnormalities in Schizophrenia Measured With Magnetic Resonance Imaging
1994
Hippocampal atrophy in recurrent major depression.
1996 Standout
Quantification of corpus callosum and ventricles in schizophrenia with nuclear magnetic resonance imaging: a pilot study
1989
Absence of regional hemispheric volume asymmetries in first-episode schizophrenia
1994
Endothelial Nitric Oxide Synthase in Vascular Disease
2006 Standout
Multicenter, Randomized, Phase II Trial of CI-1033, an Irreversible Pan-ERBB Inhibitor, for Previously Treated Advanced Non–Small-Cell Lung Cancer
2007
Epidermal Growth Factor Receptor Inhibitors in the Treatment of Non–Small-Cell Lung Cancer
2005
Serum Markers of Collagen Type I Metabolism in Spontaneously Hypertensive Rats
1996
Measuring the thickness of the human cerebral cortex from magnetic resonance images
2000 Standout
Shape and size of the corpus callosum in schizophrenia and schizotypal personality disorder
2000
Problem solving by schizophrenic and schizoaffective patients on the Wisconsin and California Card Sorting Tests.
1994
Pattern of brain morphology in patients with schizophrenia and large cavum septi pellucidi
1996
Magnetic resonance imaging measurement of posterior fossa structures in schizophrenia
1994
National Institutes of Health Consensus Development Conference Statement: Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)
2000
Epidermal Growth Factor Receptor Inhibitors in Development for the Treatment of Non–Small Cell Lung Cancer
2006
Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery
1993
Increased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease
1996
HDACs and HDAC Inhibitors in Cancer Development and Therapy
2016
Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia
1995
Qualitative assessment of brain morphology in acute and chronic schizophrenia
1992
Epigenetic regulation of redox state mediates persistent cardiorespiratory abnormalities after long‐term intermittent hypoxia
2016 StandoutNobel
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
Magnetic resonance imaging in schizophrenia: Altered brain morphology associated with P300 abnormalities and eye tracking dysfunction
1991
Dynamic mapping of human cortical development during childhood through early adulthood
2004 Standout
The Emergence of Modern Neuroscience: Some Implications for Neurology and Psychiatry
2000 StandoutNobel
The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease
2011
High throughput glutathione and Nrf2 assays to assess chemical and biological reactivity of cysteine-reactive compounds
2013
Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure
2000 Standout
Reduction in temporal lobe size in siblings with schizophrenia: A magnetic resonance imaging study
1990
Meta-analysis of corpus callosum size in schizophrenia.
1995
Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression
1999
Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
2007
What determines Wisconsin card sorting performance in schizophrenia?
1992
Patterns of neuropsychological deficits that discriminate schizophrenic individuals from siblings and control subjects
1993
Works of Stephen C. Olson being referenced
Increased Bioavailability of Intravenous Versus Oral CI-1033, a Pan erbB Tyrosine Kinase Inhibitor: Results of a Phase I Pharmacokinetic Study
2006
Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia
1998
Cavum septum pellucidum in schizophrenia, affective disorder and healthy controls: a magnetic resonance imaging study
1993
Phase I Study of Oral CI-994 in Combination with Carboplatin and Paclitaxel in the Treatment of Patients with Advanced Solid Tumors
2004
Auditory evoked potentials, clinical vs. research applications
1997
Neuropsychological deficit in schizophrenic subtypes: Paranoid, nonparanoid, and schizoaffective subgroups
1990
Perinatal brain injury and cerebellar vermal lobules I–X in schizophrenia
1991
Family history and brain morphology in schizophrenia: An MRI study
1991
The volume of the entorhinal cortex in schizophrenia: A controlled MRI study
1997
Midsagittal cerebral anatomy by magnetic resonance imaging
1989
A Phase I Clinical and Pharmacokinetic Study of Oral CI-1033 in Combination with Docetaxel in Patients with Advanced Solid Tumors
2006
The Clinical Pharmacokinetics of Quinapril
1989
Cortical atrophy in young adults with a history of hyperactivity in childhood
1986
A controlled magnetic resonance imaging study of corpus callosum thickness in schizophrenia
1986
Quinapril—A Preclinical Review of the Pharmacology, Pharmacokinetics, and Toxicology
1989
Erythromycin Coadministration Increases Plasma Atorvastatin Concentrations
1999
Pharmacodynamics and Pharmacokinetic‐Pharmacodynamic Relationships of Atorvastatin, an HMG‐CoA Reductase Inhibitor
2000
Administration of CI-1033, an Irreversible Pan-erbB Tyrosine Kinase Inhibitor, Is Feasible on a 7-Day On, 7-Day Off Schedule
2004
Hemodynamic, pharmacokinetic and clinical response to CI-930 in congestive heart failure due to ischemic or dilated cardiomyopathy
1987
Phase 1 Clinical and Pharmacokinetics Evaluation of Oral CI-1033 in Patients with Refractory Cancer
2005
Phase I Clinical and Pharmacodynamic Evaluation of Oral CI-1033 in Patients with Refractory Cancer
2007
Cognitive impairment and cerebral structure by MRI in bipolar disorder
1990
Temporal lobe asymmetry in schizophrenics by coronal MRI
1989